PetMeds adds Tamar Elkeles to its board as independent director

PetMed Express, Inc. (NASDAQ: PETS), the parent company of PetCareRx, announced the appointment of Tamar Elkeles, PhD, as a new independent director and Chair of the Compensation and Human Capital Committee, effective September 17, 2026.

Dr. Elkeles has more than three decades of experience as an executive, board member, and strategic advisor in the technology, enterprise software, and human capital industries. From 1992 to 2015, she served as Chief Learning & Talent Officer at Qualcomm, where she contributed to the company's growth from $100 million to more than $25 billion in revenue and its workforce expansion from 700 to 35,000 employees.

She currently serves as a Senior Advisor at East Wind Advisors, an Advisor at 444 Capital, and a Venture Partner at Emerge Capital. She also sits on the boards of Brightline Interactive and Open Sesame.

The appointment follows PetMeds' recent executive leadership transition, in which Jeff Willard was named Chief Executive Officer and President, succeeding Leslie C.G. Campbell, who had served as Interim CEO and President alongside her role as Chair of the Board.

"As part of our ongoing commitment to proactive board refreshment and strong corporate governance, we are thrilled to welcome Tamar to the Board," said Justin Mennen, incoming Chair of the Board.

Dr. Elkeles said she looks forward to working with the board to support the company's organizational growth priorities and drive long-term value for shareholders.

You May Also Be Interested In

• Paramount Weighs Tapping Musk For Equity Investment - Semafor
• DelphX closes C$61,000 non-brokered private placement
• Smith+Nephew launches EVOS Pelvic Plating System in the US